BD SurePath™ Process

Greater HSIL + Detection

BD FocalPoint™ Slide Profiler

BD SurePath™ Pap test and BD FocalPoint™ imaging in the lab work together to detect more HSIL+ disease.

The BD FocalPoint™ Slide Profiler (more product detail) is an FDA-approved imaging system designed to improve the ability of the cytologist and pathologist in the lab to identify cervical disease.

HSIL+ Detection With BD FocalPoint™ Screening^*

^{* Graph derived from BD FocalPoint™ Product Insert}

Combining the BD SurePath™ liquid-based Pap test, where 100% of the collected sample is sent to the lab, with the additional level of scrutiny of BD FocalPoint™ primary screening, the Cytotechnologist is more likely to find abnormals and reduce false-negatives.

The BD FocalPoint™ Slide Profiler was the first instrument to be approved as a primary screener.

The BD FocalPoint™ Slide Profiler directs the cytotechnologist’s attention to slides most likely to contain abnormality, improving disease detection over manual review.